These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 28688090)

  • 21. Structure-based selectivity optimization of piperidine-pteridine derivatives as potent Leishmania pteridine reductase inhibitors.
    Corona P; Gibellini F; Cavalli A; Saxena P; Carta A; Loriga M; Luciani R; Paglietti G; Guerrieri D; Nerini E; Gupta S; Hannaert V; Michels PA; Ferrari S; Costi PM
    J Med Chem; 2012 Oct; 55(19):8318-29. PubMed ID: 22946585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fragment quantum mechanical calculation of proteins and its applications.
    He X; Zhu T; Wang X; Liu J; Zhang JZ
    Acc Chem Res; 2014 Sep; 47(9):2748-57. PubMed ID: 24851673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenothiazine inhibitors of trypanothione reductase as potential antitrypanosomal and antileishmanial drugs.
    Chan C; Yin H; Garforth J; McKie JH; Jaouhari R; Speers P; Douglas KT; Rock PJ; Yardley V; Croft SL; Fairlamb AH
    J Med Chem; 1998 Jan; 41(2):148-56. PubMed ID: 9457238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective tight binding inhibitors of trypanosomal glyceraldehyde-3-phosphate dehydrogenase via structure-based drug design.
    Aronov AM; Verlinde CL; Hol WG; Gelb MH
    J Med Chem; 1998 Nov; 41(24):4790-9. PubMed ID: 9822549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of trypanosome alternative oxidase without its N-terminal mitochondrial targeting signal (ΔMTS-TAO) by cationic and non-cationic 4-hydroxybenzoate and 4-alkoxybenzaldehyde derivatives active against T. brucei and T. congolense.
    Ebiloma GU; Ayuga TD; Balogun EO; Gil LA; Donachie A; Kaiser M; Herraiz T; Inaoka DK; Shiba T; Harada S; Kita K; de Koning HP; Dardonville C
    Eur J Med Chem; 2018 Apr; 150():385-402. PubMed ID: 29544150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Virtual screening identification of nonfolate compounds, including a CNS drug, as antiparasitic agents inhibiting pteridine reductase.
    Ferrari S; Morandi F; Motiejunas D; Nerini E; Henrich S; Luciani R; Venturelli A; Lazzari S; Calò S; Gupta S; Hannaert V; Michels PA; Wade RC; Costi MP
    J Med Chem; 2011 Jan; 54(1):211-21. PubMed ID: 21126022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and synthesis of peptidomimetic protein farnesyltransferase inhibitors as anti-Trypanosoma brucei agents.
    Ohkanda J; Buckner FS; Lockman JW; Yokoyama K; Carrico D; Eastman R; de Luca-Fradley K; Davies W; Croft SL; Van Voorhis WC; Gelb MH; Sebti SM; Hamilton AD
    J Med Chem; 2004 Jan; 47(2):432-45. PubMed ID: 14711313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ab initio quantum mechanical study of the binding energies of human estrogen receptor alpha with its ligands: an application of fragment molecular orbital method.
    Fukuzawa K; Kitaura K; Uebayasi M; Nakata K; Kaminuma T; Nakano T
    J Comput Chem; 2005 Jan; 26(1):1-10. PubMed ID: 15521089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Profiling of Flavonol Derivatives for the Development of Antitrypanosomatidic Drugs.
    Borsari C; Luciani R; Pozzi C; Poehner I; Henrich S; Trande M; Cordeiro-da-Silva A; Santarem N; Baptista C; Tait A; Di Pisa F; Dello Iacono L; Landi G; Gul S; Wolf M; Kuzikov M; Ellinger B; Reinshagen J; Witt G; Gribbon P; Kohler M; Keminer O; Behrens B; Costantino L; Tejera Nevado P; Bifeld E; Eick J; Clos J; Torrado J; Jiménez-Antón MD; Corral MJ; Alunda JM; Pellati F; Wade RC; Ferrari S; Mangani S; Costi MP
    J Med Chem; 2016 Aug; 59(16):7598-616. PubMed ID: 27411733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How accurate can a force field become? A polarizable multipole model combined with fragment-wise quantum-mechanical calculations.
    Söderhjelm P; Ryde U
    J Phys Chem A; 2009 Jan; 113(3):617-27. PubMed ID: 19093829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimates of ligand-binding affinities supported by quantum mechanical methods.
    Söderhjelm P; Kongsted J; Genheden S; Ryde U
    Interdiscip Sci; 2010 Mar; 2(1):21-37. PubMed ID: 20640794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structures of Leishmania major pteridine reductase complexes reveal the active site features important for ligand binding and to guide inhibitor design.
    Schüttelkopf AW; Hardy LW; Beverley SM; Hunter WN
    J Mol Biol; 2005 Sep; 352(1):105-16. PubMed ID: 16055151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of N-(4-sulfamoylphenyl)thioureas as Trypanosoma brucei leucyl-tRNA synthetase inhibitors.
    Zhang F; Du J; Wang Q; Hu Q; Zhang J; Ding D; Zhao Y; Yang F; Wang E; Zhou H
    Org Biomol Chem; 2013 Aug; 11(32):5310-24. PubMed ID: 23842857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Catechol pyrazolinones as trypanocidals: fragment-based design, synthesis, and pharmacological evaluation of nanomolar inhibitors of trypanosomal phosphodiesterase B1.
    Orrling KM; Jansen C; Vu XL; Balmer V; Bregy P; Shanmugham A; England P; Bailey D; Cos P; Maes L; Adams E; van den Bogaart E; Chatelain E; Ioset JR; van de Stolpe A; Zorg S; Veerman J; Seebeck T; Sterk GJ; de Esch IJ; Leurs R
    J Med Chem; 2012 Oct; 55(20):8745-56. PubMed ID: 22963052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structures of purine nucleosidase from Trypanosoma brucei bound to isozyme-specific trypanocidals and a novel metalorganic inhibitor.
    Giannese F; Berg M; Van der Veken P; Castagna V; Tornaghi P; Augustyns K; Degano M
    Acta Crystallogr D Biol Crystallogr; 2013 Aug; 69(Pt 8):1553-66. PubMed ID: 23897478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antitrypanosomal structure-activity-relationship study of synthetic cynaropicrin derivatives.
    Usuki T; Sato M; Hara S; Yoshimoto Y; Kondo R; Zimmermann S; Kaiser M; Brun R; Hamburger M; Adams M
    Bioorg Med Chem Lett; 2014 Feb; 24(3):794-8. PubMed ID: 24433861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular interactions between estrogen receptor and its ligand studied by the ab initio fragment molecular orbital method.
    Fukuzawa K; Mochizuki Y; Tanaka S; Kitaura K; Nakano T
    J Phys Chem B; 2006 Aug; 110(32):16102-10. PubMed ID: 16898767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An evaluation of Minor Groove Binders as anti-Trypanosoma brucei brucei therapeutics.
    Scott FJ; Khalaf AI; Giordani F; Wong PE; Duffy S; Barrett M; Avery VM; Suckling CJ
    Eur J Med Chem; 2016 Jun; 116():116-125. PubMed ID: 27060763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimization of a binding fragment targeting the "enlarged methionine pocket" leads to potent Trypanosoma brucei methionyl-tRNA synthetase inhibitors.
    Huang W; Zhang Z; Ranade RM; Gillespie JR; Barros-Álvarez X; Creason SA; Shibata S; Verlinde CLMJ; Hol WGJ; Buckner FS; Fan E
    Bioorg Med Chem Lett; 2017 Jun; 27(12):2702-2707. PubMed ID: 28465105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular mechanisms of endocrine and metabolic disruption: An in silico study on antitrypanosomal natural products and some derivatives.
    Hu Z; Wahl J; Hamburger M; Vedani A
    Toxicol Lett; 2016 Jun; 252():29-41. PubMed ID: 27091077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.